Skip to content
Mesothelioma.net
phone iconCall1-800-692-8608 chat icon Chat 24/7 Live Chat
Menu
  • Malignant Mesothelioma
    • About Mesothelioma
      • How to Survive Mesothelioma
      • 100 Questions & Answers about Mesothelioma (Free Book)
      • Symptoms
      • Diagnosis
      • Prognosis
      • Life Expectancy
    • Types
      • Pleural
      • Peritoneal
      • Epithelioid
      • Sarcomatoid
      • Biphasic
    • Stages
      • Stage 1
      • Stage 2
      • Stage 3
      • Stage 4
    • Additional Information
      • Causes
      • Asbestos and Its Dangers
      • Facts
      • Support
      • Financial Compensation
      • FREE Mesothelioma Packet
  • Treatment
    • Treatment Options
      • Surgery
      • Chemotherapy
      • Radiation Therapy
      • Multimodal Therapy
      • Medications
      • Palliative Treatment
    • Find Top Doctors
      • Doctors
      • Treatment Centers
      • Treatment & Doctors Near You
      • New Treatments
      • Care Providers
      • Clinical Trials
      • Costs
  • Asbestos Trusts
  • Compensation
  • Veteran Assistance
    • Mesothelioma and Veterans
      • VA Claims for Mesothelioma
      • Vietnam Veterans
    • Military Branches and Asbestos
      • Navy Veterans
      • Navy Ships
      • Marine Corps Veterans
      • Army Veterans
      • Air Force Veterans
      • U.S. Coast Guard
  • Surviving Mesothelioma
  • About Us / Contact
  • Home
  • ›
  • Malignant Mesothelioma
  • ›
  • Types
  • ›
  • Cell Types
Page Updated: June 27, 2022

Mesothelioma Cell Types

Pinar Kanlikilicer Page Medically Reviewed and Edited by Pinar Kanlikilicer, PhD

FREE Mesothelioma Packet

Fact Checked

This page has been fact checked by a PhD who specializes in cancer research. Sources of information are listed at the bottom of the article.

FREE Mesothelioma Packet

We make every attempt to keep our information accurate and up-to-date.

Please Contact Us with any questions or comments.

There are three major mesothelioma cell types, epithelioid, sarcomatoid, and biphasic, as well as several rare subtypes.[1] Examination of the tumor cells, known as histology, can help doctors determine the type of cancer and what treatments will best help the mesothelioma patient.

FREE Mesothelioma Packet

About Mesothelioma Cell Types

The four types of mesothelioma are pleural, peritoneal, pericardial, and testicular. These describe the location of the original tumors, but also important is the type of cell in the tumors.

When doctors diagnose mesothelioma, they use histology, the study of cells, to describe the main cell types and any rare subtypes. Mesothelioma is usually diagnosed as one of three main types:

  • Epithelioid
  • Sarcomatoid
  • Biphasic

Biphasic mesothelioma is cancer with a mixture of epitheloid and sarcomatoid cells. Rare subtypes of these main types also exist.

Doctors describe mesothelioma cell types because it helps them determine a prognosis and the best course of treatment. Each cell type responds differently to treatments and progress and change in different ways.

The Study of Cells – Mesothelioma Histology

Histology is the study of cells. Mesothelioma pathology includes the use of histology to aid the diagnosis of cancers. For cancers like mesothelioma, examining the cells of a suspected tumor can tell a doctor if the patient has cancer and if it is malignant.

In some cases, these cells can also help determine where cancer originated. Mesothelioma cells are notoriously difficult to diagnose. They don’t always look different from other cancer cells. For example, pleural mesothelioma cells are very similar to lung cancer cells in morphology.

A biopsy is necessary to determine cell type for mesothelioma. A doctor takes a sample of fluid or tissue from an area of the body thought to have a tumor. The tissue sample is prepared on a microscope slide and stained to reveal the individual cells. A pathologist then examines the cells and attempts to identify them for proper diagnosis.[2]

Immunohistochemistry, a branch of histology, uses antibodies to stain tissue and fluid samples. These antibodies attach to specific antigens or proteins on certain types of cancer cells.

A pathologist can target one particular cancer cell type using immunohistochemistry, either confirming cancer or ruling it out.[1] In addition, a pathologist can also tell you the degree of your tumor’s growth rate or angiogenesis – new blood vessel formation – based on the use of immunohistochemistry markers such as ki67 or CD31.

Benign and Malignant Cells

The first way that pathologists describe biopsied cells is as malignant or benign

Unfortunately, mesothelioma cells are almost always malignant. Malignant means they are capable of growing and spreading to nearby tissues and other organs. If left untreated, malignant cells are always fatal. 

On the other hand, benign tumor cells do not spread through the body; instead, they may grow into a tumor that becomes uncomfortable or causes symptoms.

Benign mesotheliomas are rare. Some cell types that are sometimes benign include:

  • Papillary. A rare, benign type of mesothelioma is called well-differentiated papillary mesothelioma. It occurs most often in women with peritoneal tumors and can become malignant over time. The cells are described as papillary because they grow in finger-like shapes known as papillae.[3]
  • Cystic. Cystic describes tumors that are made up of smooth cysts and flat or cube-shaped cells. Benign multicystic peritoneal mesothelioma most often occurs in women.[4]
  • Adenomatoid. Very rarely, mesothelioma can develop as benign adenomatoid cells. It may occur in the mesothelium around reproductive organs or in the abdomen. Peritoneal adenomatoid mesothelioma most often occurs in men.[5]
  • Fibrous. Local fibrous tumors in the mesothelium can occur anywhere but are more common in the pleura. They may or may not cause symptoms and rarely become malignant.[5]

Epithelial Cells

When a pathologist studies cells from a person with mesothelioma, they look for the type of cell in the tumor. These cells may be epithelial, sarcomatoid, or both.

Epithelial cells are the most common type and are found in 70% of malignant mesothelioma tumors.[1] These cells have specific physical characteristics, like large nuclei and distinctive branching patterns, which are discernible under a microscope.

Epithelial cells typically respond well to treatment; therefore, an epithelial mesothelioma diagnosis is generally better news than the alternative. Because epithelial cells adhere to one another, they spread and metastasize less readily.

Sarcomatoid Cells

Compared to epithelial cells, sarcomatoid cells have a distinctive, elongated spindle shape that is easy to identify under a microscope. About 10 to 20% of mesotheliomas are diagnosed as sarcomatoid.[1]

Sarcomatoid cells are more likely to spread aggressively. Sarcomatoid mesothelioma resists treatment and often forms multiple nodules rather than one or more large tumors. The prognosis of the sarcomatoid type of cancer is worse than for epithelioid.

Biphasic Mesothelioma

If a mesothelioma tumor includes both sarcomatoid and epithelial cells, it is called biphasic.[1] Doctors will diagnose cancer as biphasic if at least 10% of its cells are one type, with the remaining cells falling into the other category.

In other words, a tumor comprised of 90% sarcomatoid cells and 10% epithelial would be considered biphasic cancer. About 25 to 30% of mesotheliomas are biphasic.

Cell Subtypes

Diagnoses may also include cell subtypes, or variants. Most variants are rare and present unique treatment challenges.

  • Deciduoid mesothelioma is a variant with epithelial cells. Originally, this unusual variant cell was mostly found in cases of peritoneal mesothelioma in young women. Approximately twenty to thirty cases of deciduoid mesothelioma are reported each year.[6]
  • Another variation is lymphohistiocytoid mesothelioma. This rare variant contains malignant inflammatory immune cells, including plasma cells, histiocytes, and lymphocytes. In addition, epithelial and sarcomatoid cells are present in the tumor. Less than 1% of pleural mesothelioma diagnoses are classified as lymphohistiocytoid.[7]
  • Desmoplastic mesothelioma most often occurs in cases of peritoneal mesothelioma. This type of mesothelioma accounts for about 5% of all cases related to asbestos exposure. Desmoplastic mesothelioma occurs when the malignant tumor triggers the fibrous growth of connective tissue, like collagen. Since this is a sarcomatoid type of cancer, the prognosis is almost always poor.[8]
  • When at least half of the cells in desmoplastic mesothelioma are of the small cell type, oncologists call it small cell desmoplastic mesothelioma. Small cells are what they sound like. They are smaller cells as compared to other types of cancer cells. Under the microscope, small cells look round, bland, and uniform.
  • Heterologous mesothelioma occurs when the tumors include cells from other parts of the body, like bone, muscle, and cartilage. In the few reported cases of this type, sarcomatoid cells predominated and the prognosis was poor.[9]

How Does Cell Type Affect Treatment?

Understanding mesothelioma cell types is important for proper treatment. Different cells and tumors require different treatment approaches.

Understanding the basic cell type and any rare variations can help a medical team determine the best treatment for an individual patient. For instance, sarcomatoid cells spread much more rapidly, requiring the most aggressive treatments.

If you have been diagnosed with mesothelioma, be sure that you receive all possible tests. This will result in a complete diagnosis as well as the most comprehensive treatment strategy.

Get Your FREE Mesothelioma Packet

Page Medically Reviewed and Edited by Pinar Kanlikilicer, PhD

Pinar Kanlikilicer

Dr. Pinar Kanlikilicer has a PhD in Biomedical Engineering. She completed her 5-years of postdoctoral training in the Department of Experimental Therapeutics at MD Anderson Cancer Center. She is currently working in the field of cancer as a research scientist.

Learn more about Cancer Research Specialist Pinar Kanlikilicer, PhD
References
  1. Inai, K. (2008, March). Pathology of Mesothelioma. Environ. Health Prev. Med. 13(2), 60-4).
    Retrieved from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2698271/
  2. National Cancer Institute. (2019, October 15). Malignant Mesothelioma Treatment (Adult) (PDQ®)–Patient Version.
    Retrieved from: https://www.cancer.gov/types/mesothelioma/patient/mesothelioma-treatment-pdq
  3. Clarke, J.M. and Helft, P. (2010). Long-Term Survival of a Woman with Well Differentiated Papillary Mesothelioma of the Peritoneum: A Case Report and Review of the Literature. J. Med. Case Reports. 4, 346.
    Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987960/
  4. Benign Multicystic Peritoneal Mesothelioma. (2021, November 8). National Institutes of Health.
    Retrieved from: https://rarediseases.info.nih.gov/diseases/10777/benign-multicystic-peritoneal-mesothelioma
  5. Coelho Lins, C.M., Elias, Jr., J., Ferreira Cunha, A., Muglia, V.F., Monteiro, C.R., Valeri, F.V., and Feres, O. (2009, March). CMR Imaging Features of Peritoneal Adenomatoid Mesothelioma: A Case Report. Clinics. 64(3), 264-9.
    Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666464/
  6. Ordonez, N.G. (2012, November). Deciduoid Mesothelioma: Report of 21 Cases With Review of the Literature. Mod. Pathol. 25(11), 1481-95.
    Retrieved from: http://www.ncbi.nlm.nih.gov/pubmed/22684220
  7. Khalidi, H.S., Medeiros, L.J., and Battifora, H. (2000, May). Lymphohistiocytoid Mesothelioma. An Often Misdiagnosed Variant of Sarcomatoid Malignant Mesothelioma. Am. J. Clin. Pathol. 113(5), 649-54.
    Retrieved from: http://www.ncbi.nlm.nih.gov/pubmed/10800396
  8. Wilson, G.E., Hasleton, P.S., and Chatterjee, A.K. (1992, April). Desmoplatic Mesothelioma: A Review of 17 Cases. J. Clin. Pathol. 45(4), 295-8.
    Retrieved from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC495267/
  9. Klebe, S., Mahar, A., Henderson, D.W., and Roggli, V.L. (2008, September). Malignant Mesothelioma With Heterologous Elements: Clinicopathological Correlation of 27 Cases and Literature Review. Mod. Pathol. 21(9), 1084-94.
    Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/18587319
View All References

Site Navigation

Home
Malignant Mesothelioma
How to Survive Mesothelioma
100 Questions & Answers about Mesothelioma (Free Book)
Surviving Mesothelioma - Beating the Odds (Free Book)
FREE Mesothelioma Packet
Symptoms
Shortness of Breath
Cough
Night Sweats and Fever
Weight Loss
Pain
Difficulty Swallowing
Fatigue and Muscle Weakness
Gastrointestinal Complications
Diagnosis
Pathology
Staging
Stage 1
Stage 2
Stage 3
Stage 4
Metastasis and Progression
Brain Metastasis
Biopsy
miRview Test
Imaging
Fine Needle Aspiration Biopsy in Mesothelioma
Biomarkers and Blood Tests
Calretinin
Prognosis
Remission
Recurrence
Death Rate
Life Expectancy
Search for a Mesothelioma Cure
Types
Pleural
Peritoneal
Epithelioid
Sarcomatoid
Biphasic
Pericardial
Testicular
Cell Types
Rare Subtypes of Mesothelioma
Deciduoid
Desmoplastic
Heterologous
Lymphohistiocytoid
Well-Differentiated Papillary
Tubulopapillary
Small Cell
Benign
Adenomatoid
Cystic
Unresectable
Localized
Idiopathic
Omental
Causes
Risk Factors
Latest Research
Genetic Components
Incidence
Latency Period
Mesothelioma Tumor
Health Insurance Coverage
Related Conditions
Immunodeficiency Disorders
Cholangiocarcinoma
Atelectasis
Pleural Plaques
Pleural Thickening
Pleural Effusion
Peritoneal Effusion (Ascites)
Mesothelial Hyperplasia and Proliferation
Pleuritis and Pleurisy
COPD
Anemia
Breast Cancer
Prevention
Complications
Misdiagnosis
Mesothelioma Commercial
Talcum Baby Powder
Lawyer
Lawsuits
Class Action Lawsuits
Settlements
Simian Virus 40
Differences From Other Cancers
Lung Cancer
Women
Children and Young Adults
Unknown Asbestos Exposure
Mesothelioma Without Asbestos
Cause of Death
Facts 
History
Awareness
Government and Research
National Mesothelioma Virtual Bank
Support
What to Expect
Living with Mesothelioma
Help a Loved One
Wrong and Right Things to Say
Caregivers
Financial Tips
Faith
Nutrition and Lifestyle
Intimacy
Mesothelioma and Fertility in Men
Fertility in Women with Mesothelioma
Emotional Health
COVID-19
Assisted Living
Hospice Care
Dying from Mesothelioma
Mourning
Coping Guide for Children
End-of-Life Decisions
Mesothelioma Awareness Day
Compensation for Victims
Lawyer
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington D.C.
Washington
West Virginia
Wisconsin
Wyoming
Lawsuit
Settlements
Statute of Limitations
Treatment
Surgery
Side Effects
Pneumonectomy
Extrapleural Pneumonectomy
Lobectomy
Pleurectomy/Decortication
Post Op Care
Pleurectomy/Decortication vs. Extrapleural Pneumonectomy
Peritonectomy/Cytoreductive Surgery
Thoracotomy
Thoracoscopy
Pericardiectomy
Wedge Resection
Pleurodesis
Pericardiocentesis
Prosthetics
Paracentesis
Thoracentesis
Chemotherapy
Side Effects
Heated Intraperitoneal
Radiation Therapy
Side Effects
Intensity-Modulated
Brachytherapy
Proton Therapy
Image-Guided
External Beam
Three-Dimensional
Multimodal Therapy
New Treatments
SMART Protocol
Gene Therapy
Suicide Gene Therapy
Tumor-Based p53 Therapy
Cryotherapy for Mesothelioma
Tumor Treating Fields
MicroRNA
Palliative Treatment
Osteopathic
Doctors
Treatment Centers
Treatment & Doctors Near You
Mesothelioma Experts
Medications
Alimta (pemetrexed)
Adriamycin (doxorubicin)
Avastin (bevacizumab)
Cytoxan (cyclophosphamide)
Gemzar (gemcitabine)
Keytruda (Pembrolizumab)
Mitomycin
Navelbine (vinorelbine)
Opdivo (nivolumab) and Yervoy (ipilimumab)
Paraplatin (carboplatin)
Platinol (cisplatin)
Rheumatrex (methotrexate)
Sutent (sunitinib)
Taxol (paclitaxel)
Medical Marijuana
Care Providers
Clinical Trials
Anetumab Ravtansine
Atezolizumab
Chimeric Antigen Receptor (CAR) T-Cell
Durvalumab
Immunotoxin
Interferon Alfa-2b
Onconase (Ranpirnase)
VISTA Protein
Costs
Immunotherapy
Nanotechnology
Hyperbaric Oxygen Therapy
Home Medical Equipment
HMGB1 Secretion
Photodynamic Therapy
Targeted Therapies
Apoptosis
Stem Cells
Lung Transplantation
Body-Based Therapies
Alternative Therapies
Paul Kraus’s Method
Doctors and Treatment in Canada
Asbestos Trusts
Veterans
VA Claims for Mesothelioma
Vietnam Veterans
Military Branches and Asbestos
Navy Veterans
Navy Ships
Aircraft Carriers
Battleships
Destroyers
Asbestos on Navy Cruisers
Submarines
Amphibious Ships
Minesweepers
Auxiliary Ships
Marine Corps Veterans
Army Veterans
Air Force Veterans
U.S. Coast Guard
Asbestos
Occupational Exposure
Construction Workers
Shipyard Workers
Ship Repair
Steel Mill Workers
Industrial Workers
Boiler Workers
Power Plant Workers
Firefighters
Automotive Workers
Roofers
Oil Refineries
Mining
Transportation Industry
Machine Operators
Farmers and Agricultural Workers
Migrant Workers
Electrical Wiring
Labor Unions
Prisons
Chimneys, Furnaces, and Wood Stoves
Fiberglass Connection to Mesothelioma
Home Remodeling
School Buildings, Teachers
For Tech Students
Cancer
Lung Cancer
Pleural Based Cancers
Ovarian Cancer
Ovarian Cancer Lawsuits
Companies That Used Asbestos
Awareness and Education
Types of Asbestos & Mesothelioma Risk
Asbestosis
Interstitial Lung Disease
Smoking
Asbestos Ingestion
Exposure in a Natural Disaster
Ban Asbestos
Libby, Montana
Recycling Asbestos
Asbestos Detection
Legal Information by State
Canada
Mexico
United Kingdom
Australia
  • Malignant Mesothelioma
    • Treatment
    • Asbestos Trusts
  • Compensation
    • Veteran Assistance
    • Surviving Mesothelioma
  • FREE Mesothelioma Packet
    • Mesothelioma News
    • About Us / Contact
  • Privacy Policy
    • Disclaimer
    • Editorial Guidelines and Standards
This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.
The information provided by Mesothelioma.net is not a substitute for professional medical advice, diagnosis or treatment.

Mesothelioma.net

5430 LBJ Freeway Suite 1200
Dallas, Texas 75240

Serving mesothelioma victims nationwide

1-800-692-8608

  • facebook
  • twitter
© 2022 Mesothelioma.net